Flow Cytometry Immunophenotyping (FCI) of Fine Needle Aspirates (FNAs) of Lymph Nodes

被引:1
|
作者
Paro, Mirjana Mariana Kardum [1 ]
Siftar, Zoran [1 ]
Kardum-Skelin, Ika [2 ,3 ]
Sustercic, Dunja [2 ]
Nazor, Aida [1 ]
Flegar-Mestric, Zlata [1 ,4 ]
Jaksic, Branimir [3 ]
机构
[1] Merkur Univ Hosp, Inst Clin Chem, Zagreb, Croatia
[2] Merkur Univ Hosp, Lab Cytol & Hematol, Dept Med, Zagreb, Croatia
[3] Univ Zagreb, Sch Med, Zagreb 41001, Croatia
[4] Univ Zagreb, Fac Pharm & Biochem, Zagreb 41000, Croatia
关键词
flow cytometry immunophenotyping (FCI); fine needle aspirates (FNAs); CANADIAN CONSENSUS RECOMMENDATIONS; NON-HODGKINS-LYMPHOMAS; HEMATOLOGIC NEOPLASIA; CYTOLOGIC SPECIMENS; DIAGNOSIS; LIGHT; LIMITATIONS; DISEASES; BLOOD;
D O I
暂无
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
Flow cytometry immunophenotyping (FCI) has an important role in the clinic work-up of fine needle aspirates (FNAs) of lymph nodes. Its standardization has been defined by proposed analytical protocols and procedures used to assure proper analytical results also in those non-routine samples. In Institute of Clinical Chemistry, "Merkur" University Hospital, FCI is accredited method according to laboratory accreditation standard ISO 15189. According to this laboratory accreditation standard, participation in external quality assessment (EQA) programs is a prerequisite for assuring integrity and quality of the entire laboratory process. A critical analysis of our institutional experience in the feasibility of FCI of the material obtained by FNA of lymph nodes with suspected lymphoma represented the purpose of the study. During an eight-year period in Institute of Clinical Chemistry, "Merkur" University Hospital, a total of 1295 FNA analysis was done, 245 of them with a possible diagnosis of B-cell Non-Hodgkin lymphomas (B-NHL) formed the basis of the study. Lymphocytes were isolated on density gradient according to Boyum et al. The average feasibility of FNAs for FCI analysis was 86 % (ranged 78-93%). An acceptable total cell number in FNAs for FCI analysis (4257) was established. In total population of respondents statistical significances in expressions of cellular antigens CD3, CD5, CD22, CD23, CD19 and CD5 on B-cells (CD5 + CD19 +) between patient's with final diagnosis of benign, reactive lymphoid proliferations and patient 's with diagnosis of B-NHL were found. EQA results analysis showed that all results were either inside target values ((X) over bar+/-1SD) or inside accepted values ((X) over bar+/-2SD). Compatibility of the restriction of imunoglobulins light chains determinated by FCI and cytomorphology diagnosis depends on the choice of criterion values of the light chains ratio which determine the monoclonality. According to the matrix of shares of all classified data of retained neural network, ranges of diagnostic sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and prevalency of 82%, 72%, 93%, 48%, and 72% were produced. As a conclusion, FCI is a reliable methodology for phenotyping FNAs of lymph nodes with suspected B-NHLs detecting their clonality easily.
引用
收藏
页码:359 / 365
页数:7
相关论文
共 50 条
  • [1] Flow cytometry screening of fine needle aspirates (FNAS)
    Arroz, M
    Chorao, M
    Pinto, L
    Gregório, C
    Pedrosa, I
    Krasteva, E
    Matos, MR
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2005, 68B (01) : 53 - 54
  • [2] Utility of fine needle cytology (FNC) and flow cytometry immunophenotyping (FCI) to diagnose lymphoid disorders
    D'Arena, G.
    Cascavilla, N.
    Napolitano, M.
    Corazzelli, G.
    Frigeri, F.
    Marcacci, G.
    Minervini, M. M.
    Savino, L.
    Mauro, F.
    Pinto, A.
    Fulciniti, F.
    CYTOMETRY PART A, 2008, 73A (01) : 80 - 80
  • [3] Immunophenotyping by flow cytometry of fine needle aspirates in the diagnosis of lymphoproliferative disorders: A retrospective study
    Henrique, RMF
    Sousa, ME
    Godinho, MI
    Costa, I
    Barbosa, IL
    Lopes, CAS
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1999, 13 (05) : 224 - 228
  • [4] Use of fine needle aspirates and flow cytometry for the diagnosis, classification, and immunophenotyping of canine lymphomas
    Sözmen, M
    Tasca, S
    Carli, E
    De Lorenzi, D
    Furlanello, T
    Caldin, M
    JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, 2005, 17 (04) : 323 - 330
  • [5] Flow cytometric immunophenotyping in fine-needle aspiration of lymph nodes
    Chung, JG
    Gong, GY
    Huh, JY
    Khang, SK
    Ro, JY
    JOURNAL OF KOREAN MEDICAL SCIENCE, 1999, 14 (04) : 393 - 400
  • [6] Defining Normal: Flow Cytometry Immunophenotyping of Benign Lymph Nodes Sampled by Fine Needle Aspiration or Surgical Biopsy
    Scott, Gregory
    Gratzinger, Dita
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 149 : S85 - S85
  • [7] The value of "Reflex" flow cytometry analysis on fine needle aspirates of reactive lymph nodes and non-Hodgkin lymphomas
    Bruzzi, Cynthia M.
    DePalma, Louis
    Berezowski, Katherine
    CANCER CYTOPATHOLOGY, 2007, 111 (05): : 413 - 414
  • [8] Chromosomal abnormalities and DNA image cytometry of haematological neoplasms in fine needle aspirates of lymph nodes
    Borovecki, A
    Kardum-Skelin, I
    Sustercic, D
    Hitrec, V
    Lasan, R
    Jaksic, B
    CYTOPATHOLOGY, 2003, 14 (06) : 320 - 326
  • [9] Contribution of flow cytometry immunophenotyping (FCI) to the diagnosis of lymphoma in fine needle aspirate (FNA) and tissues biopsy (TB) specimens
    Banas Llanos, M. H.
    Garcia Suarez, J.
    Lopez Rubio, M.
    Gil Fernandez, J. J.
    Martinez Onsurbe, P.
    Gonzalez Estecha, A.
    Olmedilla Arregui, G.
    Guindal, B.
    Pardilla, V.
    Pascual, T.
    Martin Guerrero, Y.
    Calero, M. A.
    Masso, P.
    Perera, F.
    Burgaleta, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 466 - 466
  • [10] The accuracy of combined cytopathologic and flow cytometric analysis of fine-needle aspirates of lymph nodes
    Nicol, TL
    Silberman, M
    Rosenthal, DL
    Borowitz, MJ
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (01) : 18 - 28